INTERLEUKIN (IL) 1-BETA, IL-1 RECEPTOR ANTAGONIST, IL-10, AND IL-13 GENE-EXPRESSION IN THE CENTRAL-NERVOUS-SYSTEM AND ANTERIOR-PITUITARY DURING SYSTEMIC INFLAMMATION - PATHOPHYSIOLOGICAL IMPLICATIONS
Ml. Wong et al., INTERLEUKIN (IL) 1-BETA, IL-1 RECEPTOR ANTAGONIST, IL-10, AND IL-13 GENE-EXPRESSION IN THE CENTRAL-NERVOUS-SYSTEM AND ANTERIOR-PITUITARY DURING SYSTEMIC INFLAMMATION - PATHOPHYSIOLOGICAL IMPLICATIONS, Proceedings of the National Academy of Sciences of the United Statesof America, 94(1), 1997, pp. 227-232
The pathophysiology of systemic inflammation and sepsis involves perip
heral organs, causing gastrointestinal, renal, and cardiovascular alte
rations, as well as the central nervous system (CNS), affecting sleep,
temperature regulation, behavior, and neuroendocrine function, The mo
lecular basis of the CNS effects of systemic inflammation are not full
y elucidated, Here we show that the CNS responds to systemic inflammat
ion with pronounced IL-1 beta gene expression and limited IL-1 recepto
r antagonist (IL-1ra), IL-10, and IL-13 gene expression, This pattern
occurs throughout the CNS, including areas such as the subfornical org
an, pineal gland, neurohypophysis, and hypothalamus. In contrast, in t
he anterior pituitary, we found limited IL-1 beta gene expression but
marked induction of the mRNA encoding for the secreted isoform of IL-1
ra, secreted IL-1ra. We conclude that the central manifestations of pe
ripheral inflammation are mediated by endogenous brain IL-1 beta synth
esized during systemic inflammation in the context of limited central
cytokine counter regulation of IL-1. As IL-1 beta is a potent stimulus
for inducible nitric oxide synthase expression and activity, these fi
ndings explain our previous observation that systemic inflammation pro
motes inducible nitric oxide synthase gene expression in the brain and
the spillover of NO metabolites into cerebrospinal fluid, The CNS tra
nscription of the HIV-1 replication factor IL-1 beta in the context of
limited transcription of the IL-1 replication inhibitors IL-1ra, IL-1
0, and IL-13 might help explain the negative impact of systemic inflam
mation on the clinical course of AIDS. In addition, we propose that IL
-1ra may be secreted by the anterior pituitary as a systemic anti-infl
ammatory hormone that is released in response to IL-1 beta originated
from multiple sources.